Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-mutation signatures are age-dependent and impact the prognosis in <i>NPM1</i>-mutated acute myeloid leukemia: a PETHEMA multicenter study.

Haematologica·2026
Same author

Value of Genetically Rare Cord Blood Units Beyond Conventional Quality Metrics.

HLA·2026
Same author

Validation of ELN 2024 genetic classification in patients with AML treated with HMA-based regimens: PETHEMA registry study.

Blood neoplasia·2026
Same author

Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA study.

Blood·2026
Same author

Analysis of a radon mitigation system using sub-slab air chamber: CFD model development and validation in an experimental case.

Journal of environmental radioactivity·2026
Same author

Impact of hematopoietic cell transplantation and quizartinib in patients with newly diagnosed FLT3-internal tandem duplication-negative acute myeloid leukemia: results from the QUIWI study.

Haematologica·2026

Related Experiment Video

Updated: May 6, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

6.6K

WT1 isoform expression pattern in acute myeloid leukemia.

Irene Luna1, Esperanza Such, Jose Cervera

  • 1Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Leukemia Research
|November 12, 2013
PubMed
Summary

Wilms tumor 1 (WT1) isoforms show altered expression in acute myeloid leukemia (AML). Isoform D is predominant in AML, but decreased compared to normal cells, suggesting a role in leukemia development.

Keywords:
Acute myeloid leukemiaWT1 isoforms

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

959
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

9.3K

Related Experiment Videos

Last Updated: May 6, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

6.6K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

959
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

9.3K

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • The Wilms tumor 1 (WT1) gene is implicated in various cancers, including acute myeloid leukemia (AML).
  • WT1 exhibits a dual role in leukemia development, potentially linked to the differential expression of its main isoforms.
  • Understanding WT1 isoform expression is crucial for deciphering its role in AML pathogenesis.

Purpose of the Study:

  • To quantify the expression levels of the four main WT1 isoforms in AML patients.
  • To evaluate the correlation between WT1 isoform expression and AML.
  • To investigate the potential mechanisms underlying WT1 overexpression in AML.

Main Methods:

  • Quantitative analysis of WT1 isoform expression.
  • Evaluation of WT1 isoform expression in a series of AML patient samples.
  • Comparison of WT1 isoform expression in AML patients versus normal CD34+ cells.

Main Results:

  • A predominant expression of WT1 isoform D was observed in AML patients.
  • WT1 isoform D expression in AML was lower compared to normal CD34+ cells.
  • A positive correlation was found between total WT1 expression and the expression of WT1 isoforms A, B, and C.

Conclusions:

  • The overexpression of WT1 in AML may result from a relative increase in WT1 isoforms A, B, and C.
  • A concurrent relative decrease in WT1 isoform D expression might contribute to AML development.
  • Altered WT1 isoform balance is a potential factor in the dual role of WT1 in leukemia.